| Literature DB >> 36118715 |
Elshaima Mohamed Fawzi1, AbdelKarem Mansour Morsi2, Eman Beshry Abd-Elfatah1.
Abstract
Background: Lumpy skin disease (LSD) is endemic in Egypt despite the Egyptian authorities' annual mass vaccination of cattle with sheeppox vaccine (Veterinary Serum and Vaccine Research Institute, Egypt), and the LSD virus (LSDV) continues to thrive practically every summer. The disease has a huge economic impact on the trade of the animal and its by-product. Aim: This paper study the molecular characterization of LSDV strains that have been circulating in Sharkia Governorate, Egypt, for three successive years (2018, 2019, and 2020).Entities:
Keywords: Cattle; Egypt; Lumpy skin disease; PCR; Phylogenetic analysis
Mesh:
Substances:
Year: 2022 PMID: 36118715 PMCID: PMC9473367 DOI: 10.5455/OVJ.2022.v12.i4.6
Source DB: PubMed Journal: Open Vet J ISSN: 2218-6050
Primers sequences sets, target genes, amplicon sizes, and optimized cycling conditions concerning conventional PCR assay of ORF 103 gene.
| Target gene | Primers sequences | Amplified segment (bp) | Primary denaturation | Amplification (35 cycles) | Final extension | ||
|---|---|---|---|---|---|---|---|
| Secondary denaturation | Annealing | Extension | |||||
| ORF 103 | Forward primer: 5'- ATGTCTGATAAAAAATTATCTCG -3' | 570 | 94°C | 94°C | 52°C | 72°C | 72°C |
| Reverse primer: 5'- ATCCATACCATCGTCGATAG-3' | |||||||
Fig. 1.Cattle with characteristic of LSDV. (a and b) Generalized circumscribed active nodules covering entire body; (c) nodules on head with lacrimation; and (d and e) progression of the disease with the observation of eroded and crusted nodules and scab formation.
The data of collected LSD samples either nodules or oculonasal swabs during three outbreaks (2018, 2019, and 2020) from cattle by conventional PCR with demarcation of the incidence.
| Outbreak years | Skin scabs and nodule | Occulonasal swabs | Total | |||
|---|---|---|---|---|---|---|
| No. | Positive | No. | Positive | No. | Positive | |
| 2018 | 11 | 11/100% | 8 | 5/62.5% | 19 | 16/84% |
| 2019 | 6 | 6/100% | 16 | 9/56.25% | 22 | 15/68.2% |
| 2020 | 9 | 9/100% | 11 | 6/54.5% | 20 | 15/75% |
| Total | 26 | 26/100% | 35 | 20/57% | 61 | 46/75.4 |
Fig. 2.Agarose gel electrophersis picture of PCR product showing the amplification of fragment of ORF103 gene at 570 bp. P: Control positive; L: DNA ladder; Lane 1: Negative fragment of LSDV in samples taken from oculonasal swabs; Lanes 4,5,9: Positive fragment of LSDV in samples taken from oculonasal swabs; Lanes 2,3,6,7,8: Positive fragment of LSDV in samples taken from scabs and skin nodules specimens.
Fig. 3.Phylogentic analysis of 27 CaPVs based on nucleotide sequences of ORF103 gene derived from Genebank and drawn by MEGA6.
Details and identity % of selected CaPVs sequences based on ORF103 gene used to construct phylogenetic tree.
| Accession no. | Origin | Identity% |
|---|---|---|
| AF325528 LSD NI-2490 | 2001, USA | 99.65%–99.47% |
| KX683219 LSD KSGP 0240 | A commercial live attenuated vaccine Belgium, 2016 | 99.65%–99.47% |
| KX894508 LSD 155920/2012 | Outbreak in Israel in 2012 | 100%–99.82% |
| KY829023 LSD Evros/GR/ | Greece in 2015 | 100%–99.82% |
| KY702007 LSD SERBIA/Bujanovac/2016 | SERBIA/Bujanovac/2016 | 100%–99.82% |
| KX764644 LSD Neethling-Herbivac | Complete genome sequences of the Neethling-like LSDV strains from three commercial live attenuated vaccines 2016, Belgium | 98.77%–98.60% |
| KX764643 LSD SIS-Lumpyvax | Complete genome sequences of the Neethling-like LSDV strains from three commercial live attenuated vaccines 2016, Belgium | 98.77%–98.60% |
| MK342935 LSD CPD/Menofiya1/2018 | Nodules and scabs from skin lesions Menofiya 1/2018 | 99.82%–100% |
| MN072619 LSD Kenya | 2019, Kenya | 99.65%–99.47% |
| MN792930 LSD/AHRI/ALWadi Elgidid/2018 | LSD/AHRI/ALWadi Elgidid/Egypt/saad/2018 | 99.80%–100.00% |
| MH893760 LSD/Russia/Dagestan/2015 | Russia/Dagestan/2015 | 100%–99.82% |
| MT992618 LSD KZ-Kostanay- | Kostanay, 2018 | 99.65%–99.47% |
MW357655 LSD Zag 1 | Nasal and ocular swab 2020-Zagazig | |
MW357656 LSD Zag 2 | Nasal and ocular swab 2018-Zagazig | 99.82% |
MW357657 LSD Zag 3 | Nodules 2018-Zagazig | 99.82% |
MW357658 LSD Zag 4 | Nodules 2020-Zagazig | 100% |
MW357659 LSD Zag 5 | Nodules 2019-Zagazig | 99.82% |
MW357660 LSD Zag 6 | Nodules 2020-Zagazig | 100% |
MW357661 LSD Zag 7 | Nodules 2019-Zagazig | 99.82% |
| KX576657 GTPV Gorgan | Belgium, 2016 | 98.25%–98.07% |
| MH381810 GTPV AV41 | China, 2018 | 98.07%–97.89% |
| KX398512 GTPV/Sambalpur/2001/P6 | India, 2001 | 98.07%–97.89% |
| KX398496 GTPV/Mukteswar/1946/P50 | India, 1946 | 98.07%–97.89% |
| MG000156 SPPV Jaipur | India, 1981 | 97.54%–97.37% |
| KT438551 SPPV-GL | China, 2013 | 97.54%–97.37% |
| MF443334 SPPV El-Minufiya | El-Minufiya, 2016 | 97.54%–97.37% |
| AY077833 SPPV A | Kazakhstan, 2000 | 97.54%–97.37% |
Fig. 4.The pairwise heatmap shows the distance matrix between each pair of isolates to determine degree of similarity and diversity relationship among selected CaPVs sequences. The heatmap was generated using R software (package: plot.matrix).
Fig. 5.Amino acid sequences alignment of ORF103 gene of current field isolates and related to LSD either virus or vaccine and SPPV and GTPV generated from database of GenBank.